Epidemiology and Biostatistics Unit, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium
Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, Adelaide, South Australia's, Australia.
BMJ Glob Health. 2021 Jun;6(6). doi: 10.1136/bmjgh-2021-005634.
During the last decade, many studies have assessed the performance of malaria tests on non-invasively collected specimens, but no systematic review has hitherto estimated the overall performance of these tests. We report here the first meta-analysis estimating the diagnostic performance of malaria diagnostic tests performed on saliva, urine, faeces, skin odour ('sniff and tell') and hair, using either microscopy or PCR on blood sample as reference test.
We searched on PubMed, EMBASE, African Journals Online and Cochrane Infectious Diseases from inception until 19 January 2021 for relevant primary studies. A random effects model was used to estimate the overall performance of various diagnostic methods on different types of specimen.
Eighteen studies providing 30 data sets were included in the meta-analysis. The overall sensitivity, specificity and diagnostic OR (DOR) of PCR were 84.5% (95% CI 79.3% to 88.6%), 97.3% (95% CI 95.3% to 98.5%) and 184.9 (95% CI 95.8 to 356.9) in saliva, respectively; 57.4% (95% CI 41.4% to 72.1%), 98.6% (95% CI 97.3% to 99.3%) and 47.2 (95% CI 22.1 to 101.1) in urine, respectively. The overall sensitivity, specificity and DOR of rapid diagnostic test for malaria in urine was 59.8% (95% CI 40.0% to 76.9%), 96.9% (95% CI 91.0% to 99.0%) and 30.8 (95% CI:23.5 to 40.4).
In settings where PCR is available, saliva and urine samples should be considered for PCR-based malaria diagnosis only if blood samples cannot be collected. The performance of rapid diagnostic testing in the urine is limited, especially its sensitivity. Malaria testing on non-invasively collected specimen still needs substantial improvement.
在过去十年中,许多研究评估了针对非侵入性采集标本的疟疾检测的性能,但迄今尚无系统评价来评估这些检测的总体性能。我们在此报告第一项荟萃分析,该分析使用血液样本中的显微镜检查或 PCR 作为参考检测,估计了在唾液、尿液、粪便、皮肤气味(“嗅探和告知”)和头发上进行的疟疾诊断检测的诊断性能。
我们在 PubMed、EMBASE、African Journals Online 和 Cochrane Infectious Diseases 上搜索了从成立到 2021 年 1 月 19 日的相关原始研究。使用随机效应模型来估计各种诊断方法在不同类型标本上的总体性能。
18 项研究提供了 30 个数据集,包括在荟萃分析中。PCR 在唾液中的总体敏感性、特异性和诊断比值比(DOR)分别为 84.5%(95%CI 79.3%至 88.6%)、97.3%(95%CI 95.3%至 98.5%)和 184.9(95%CI 95.8 至 356.9);57.4%(95%CI 41.4%至 72.1%)、98.6%(95%CI 97.3%至 99.3%)和 47.2(95%CI 22.1%至 101.1)在尿液中分别。尿液中快速诊断检测疟疾的总体敏感性、特异性和 DOR 分别为 59.8%(95%CI 40.0%至 76.9%)、96.9%(95%CI 91.0%至 99.0%)和 30.8(95%CI:23.5 至 40.4)。
在可以进行 PCR 的情况下,如果无法采集血液样本,应仅考虑针对唾液和尿液样本进行基于 PCR 的疟疾诊断。尿液中快速诊断检测的性能有限,特别是其敏感性。非侵入性采集标本的疟疾检测仍需要大幅改进。